• Türkçe
    • English
  • Türkçe 
    • Türkçe
    • English
  • Giriş
Öğe Göster 
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • Scopus İndeksli Yayınlar Koleksiyonu
  • Öğe Göster
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • Scopus İndeksli Yayınlar Koleksiyonu
  • Öğe Göster
JavaScript is disabled for your browser. Some features of this site may not work without it.

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

Göster/Aç

Tam Metin / Full Text (695.4Kb)

Erişim

info:eu-repo/semantics/openAccess

Tarih

2024

Yazar

Younossi, Zobair M.
AlQahtani, Saleh A.
Funuyet-Salas, Jesús
Romero-Gómez, Manuel
Yılmaz, Yusuf
Keklikkıran, Çağlayan
Alswat, Khalid
Yu, Ming-Lung
Liu, Chun-Jen
Fan, Jian-Gao
Zheng, Ming-Hua
Burra, Patrizia
Francque, Sven M.
Castera, Laurent
Schattenberg, Jörn M.
Newsome, Philip N.
Allen, Alina M.
El-Kassas, Mohamed
Treeprasertsuk, Sombat
Hameed, Saeed
Wai-Sun Wong, Vincent
Zelber-Sagi, Shira
Takahashi, Hirokazu
Kawaguchi, Takumi
Castellanos Fernández, Marlen I.
Duseja, Ajay
Arrese, Marco
Rinella, Mary
Singal, Ashwani K.
Gordon, Stuart C.
Fuchs, Michael
Eskridge, Wayne
Alkhouri, Naim
Cusi, Kenneth
Loomba, Rohit
Ranagan, Jane
Kautz, Achim
Ong, Janus P.
Kugelmas, Marcelo
Eguchi, Yuichiro
Diago, Moises
Gerber, Lynn
Lam, Brian
Fornaresio, Lisa
Nader, Fatema
Spearman, C. Wendy
Roberts, Stuart K.
Chan, Wah-Kheong
Silva, Marcelo
Racila, Andrei
Golabi, Pegah
Ananchuensook, Prooksa
Henry, Linda
Stepanova, Maria
Carrieri, Patrizia
Lazarus, Jeffrey V.

Üst veri

Tüm öğe kaydını göster

Künye

Younossi, Z. M., AlQahtani, S. A., Funuyet-Salas, J., Romero-Gómez, M., Yilmaz, Y., Keklikkiran, C., Alswat, K., Yu, M.-L., Liu, C.-J., Fan, J.-G., Zheng, M.-H., Burra, P., Francque, S. M., Castera, L., Schattenberg, J. M., Newsome, P. N., Allen, A. M., El-Kassas, M., Treeprasertsuk, S., . . . Lazarus, J. V. (2024). The Impact of Stigma on Quality of Life and Liver Disease Burden Among Patients with Nonalcoholic Fatty Liver Disease. JHEP Reports, 6(7), 101066. https://doi.org/10.1016/j.jhepr.2024.101066

Özet

Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality of life (HRQL) and potential stigmatization. We aimed to assess the burden of liver disease in patients with NAFLD and the relationship between experience of stigma and HRQL. Methods: Members of the Global NASH Council created a survey about disease burden in NAFLD. Participants completed a 35-item questionnaire to assess liver disease burden (LDB) (seven domains), the 36-item CLDQ-NASH (six domains) survey to assess HRQL and reported their experience with stigmatization and discrimination. Results: A total of 2,117 patients with NAFLD from 24 countries completed the LDB survey (48% Middle East and North Africa, 18% Europe, 16% USA, 18% Asia) and 778 competed CLDQ-NASH. Of the study group, 9% reported stigma due to NAFLD and 26% due to obesity. Participants who reported stigmatization due to NAFLD had substantially lower CLDQ-NASH scores (all p <0.0001). In multivariate analyses, experience with stigmatization or discrimination due to NAFLD was the strongest independent predictor of lower HRQL scores (beta from -5% to -8% of score range size, p <0.02). Experience with stigmatization due to obesity was associated with lower Activity, Emotional Health, Fatigue, and Worry domain scores, and being uncomfortable with the term “fatty liver disease” with lower Emotional Health scores (all p <0.05). In addition to stigma, the greatest disease burden as assessed by LDB was related to patients’ self-blame for their liver disease. Conclusions: Stigmatization of patients with NAFLD, whether it is caused by obesity or NAFLD, is strongly and independently associated with a substantial impairment of their HRQL. Self-blame is an important part of disease burden among patients with NAFLD. Impact and implications: Patients with nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD), may experience impaired health-related quality of life and stigmatization. Using a specifically designed survey, we found that stigmatization of patients with NAFLD, whether it is caused by obesity or the liver disease per se, is strongly and independently associated with a substantial impairment of their quality of life. Physicians treating patients with NAFLD should be aware of the profound implications of stigma, the high prevalence of self-blame in the context of this disease burden, and that providers’ perception may not adequately reflect patients’ perspective and experience with the disease.

Kaynak

JHEP Reports

Cilt

6

Sayı

7

Bağlantı

https://doi.org/10.1016/j.jhepr.2024.101066
https://hdl.handle.net/11436/9202

Koleksiyonlar

  • PubMed İndeksli Yayınlar Koleksiyonu [2443]
  • Scopus İndeksli Yayınlar Koleksiyonu [5931]
  • TF, Dahili Tıp Bilimleri Bölümü Koleksiyonu [1559]
  • WoS İndeksli Yayınlar Koleksiyonu [5260]



DSpace software copyright © 2002-2015  DuraSpace
İletişim | Geri Bildirim
Theme by 
@mire NV
 

 




| Yönerge | Rehber | İletişim |

DSpace@RTEÜ

by OpenAIRE
Gelişmiş Arama

sherpa/romeo

Göz at

Tüm DSpaceBölümler & KoleksiyonlarTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile GöreBölüme GöreKategoriye GöreYayıncıya GöreErişim ŞekliKurum Yazarına GöreBu KoleksiyonTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile GöreBölüme GöreKategoriye GöreYayıncıya GöreErişim ŞekliKurum Yazarına Göre

Hesabım

GirişKayıt

İstatistikler

Google Analitik İstatistiklerini Görüntüle

DSpace software copyright © 2002-2015  DuraSpace
İletişim | Geri Bildirim
Theme by 
@mire NV
 

 


|| Rehber|| Yönerge || Kütüphane || Recep Tayyip Erdoğan Üniversitesi || OAI-PMH ||

Recep Tayyip Erdoğan Üniversitesi, Rize, Türkiye
İçerikte herhangi bir hata görürseniz, lütfen bildiriniz:

Creative Commons License
Recep Tayyip Erdoğan Üniversitesi Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@RTEÜ:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.